Illumina logo

Illumina

ILMN | NASDAQ
Chart Builder DCF Calculator
$198.00
-$9.01 (-4.35%)
At close: Nov 16, 2026, 4:00 PM ET
$199.99
+$1.99 (+1.01%)
After-hours: Nov 16, 2026, 7:39 PM ET
-4.35%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
59.5
Fundamentals Strong
Market Sentiment Neutral
Moat Wide
Sector Rank #137/1021 (Top 13%)

Key Statistics

Market Data

Market Cap $29.94B
1D Range
197.38 203.31
52W Range
114.44 293.69

Valuation (TTM)

PE 34.02
PB 9.52
EV/EBITDA 22.24

Valuation (NTM)

Forward PE 38.19
Forward PEG 2.42
Price Target $267.50
Loading financial charts...

Profile

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sector...

Sector Healthcare
Employees 8,600
IPO Date Jul 28, 2000
Fiscal Year February - January

Latest News

Thrivent Mid Cap Stock Fund Q3 2026 Performance Review

2 hours ago · seekingalpha.com

Thrivent Mid Cap Stock Fund Q3 2026 Performance Review
Illumina Bets on Clinical Demand for Growth as Research Funding Uncertainty Persists

6 days ago · marketbeat.com

Illumina Bets on Clinical Demand for Growth as Research Funding Uncertainty Persists
Illumina, Inc. (ILMN) Presents at 2026 UBS Global Healthcare Conference Transcript

6 days ago · seekingalpha.com

Illumina, Inc. (ILMN) Presents at 2026 UBS Global Healthcare Conference Transcript
Illumina advances MRD research portfolio with ultrasensitive duplex sequencing technology

8 days ago · prnewswire.com

Illumina advances MRD research portfolio with ultrasensitive duplex sequencing technology
3 Stocks to Watch Following Guidance Upgrades

14 days ago · zacks.com

3 Stocks to Watch Following Guidance Upgrades
Illumina selected to help bring precision medicine into everyday healthcare in Singapore

14 days ago · prnewswire.com

Illumina selected to help bring precision medicine into everyday healthcare in Singapore
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term

15 days ago · zacks.com

Why Illumina (ILMN) is a Top Growth Stock for the Long-Term
Don't Overlook Illumina (ILMN) International Revenue Trends While Assessing the Stock

15 days ago · zacks.com

Don't Overlook Illumina (ILMN) International Revenue Trends While Assessing the Stock
ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth

18 days ago · zacks.com

ILMN Q3 Earnings Call Highlights Higher Guidance and Clinical Growth
Illumina (ILMN) Reports Q3 Earnings: What Key Metrics Have to Say

18 days ago · zacks.com

Illumina (ILMN) Reports Q3 Earnings: What Key Metrics Have to Say

Earnings

Latest Earnings
Oct 29, 2026
EPS
$1.62
Beat +19.12%
REV
$1.17B
Beat +1.12%
Next Earnings
Feb 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
13
Consensus
Buy
Price Target
$260.00
Upside
+31.31%
Buy (9)
Hold (2)
Sell (2)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.